Time-Restricted Eating Regimen Differentially Affects Circulatory miRNA Expression in Older Overweight Adults
Saini SK, Singh A, Saini M, Gonzalez-Freire M, Leeuwenburgh C, Anton SD
Nutrients · 25 citations
How it was studied
- Design
- Controlled clinical trial (indexed by PubMed)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
- Government
- Council of Scientific and Industrial Research, India
- Government
- National Institutes of Health
- Government
- Instituto de Salud Carlos III
- Government
- National Institute on Aging
- Government
- NIA NIH HHS
- Government
- NIH HHS
- Grants
- National Institute on Aging (P30 AG028740); National Institutes of Health (P30AG028740)
Based on 6 listed funder(s) and full-text disclosure statement.
Publication
- Published
- 2022-04-28 · Nutrients · vol. 14 · issue 9 · p. 1843
- Publisher
- Multidisciplinary Digital Publishing Institute
- Cited
- 30 citations · more than 93% of similar papers · 3.0× the field average
- Impact
- Top 10% most cited in its field
- References
- 47 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Dietary Effects on Health · Circadian rhythm and melatonin · Hydrogen's biological and therapeutic effects
- Keywords
- Overweight, microRNA, Regimen, Circulatory system, Young adult, Gerontology, Medicine, Physiology, Internal medicine, Psychology, Biology, Body mass index, Genetics, Gene
- MeSH
- humans, weight loss, micrornas, fasting, pilot projects, adult, aged, overweight
6 authors
From US, IN, ES
- Sunil Kumar SainiUniversity of Florida; Institute on Aging; All India Institute of Medical Sciences
- Arashdeep SinghUniversity of Florida
- Manisha Saini
- Marta González‐FreireHealth Research Institute of the Balearic Islands
- Christiaan LeeuwenburghUniversity of Florida; Institute on Aging
- Stephen Douglas Anton · correspondingUniversity of Florida Health; University of Florida; Institute on Aging
Abstract
Time-restricted eating (TRE), a popular form of intermittent fasting, has been demonstrated to provide multiple health benefits, including an extension of healthy lifespan in preclinical models. While the specific mechanisms remain elusive, emerging research indicates that one plausible mechanism through which TRE may confer health benefits is by influencing the expression of the epigenetic modulator circulatory miRNAs, which serve as intercellular communicators and are dysregulated in metabolic disorders, such as obesity. Therefore, the goal of this pilot study is to examine the effects of a 4-week TRE regimen on global circulatory miRNA from older (≥65 years) overweight participants. Pre- and post-TRE regimen serum samples from nine individuals who participated in the Time to Eat clinical trial (NCT03590847) and had a significant weight loss (2.6 kg, p < 0.01) were analyzed. The expressions of 2083 human miRNAs were quantified using HTG molecular whole transcriptome miRNA assay. In silico analyses were performed to determine the target genes and biological pathways associated with differentially expressed miRNAs to predict the metabolic effects of the TRE regimen. Fourteen miRNAs were differentially expressed pre- and post-TRE regimen. Specifically, downregulated miRNA targets suggested increased expression of transcripts, including PTEN, TSC1, and ULK1, and were related to cell growth and survival. Furthermore, the targets of downregulated miRNAs were associated with Ras signaling (cell growth and proliferation), mTOR signaling (cell growth and protein synthesis), insulin signaling (glucose uptake), and autophagy (cellular homeostasis and survival). In conclusion, the TRE regimen downregulated miRNA, which, in turn, could inhibit the pathways of cell growth and activate the pathways of cell survival and might promote healthy aging. Future mechanistic studies are required to understand the functional role of the miRNAs reported in this study.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.